Hartford Healthcare’s team remains strong after several personnel changes in recent years, and its well-established and attractive approach remains intact. The strategy retains its People and Process Pillar ratings of Above Average.
The Hartford Healthcare Fund Class Y HGHYX
- NAV / 1-Day Return 51.65 / −1.32 %
- Total Assets 775.8M
-
Adj. Expense Ratio
1.050%
- Expense Ratio 1.050%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Health
- Investment Style Large Blend
- Min. Initial Investment 250,000
- Status Open
- TTM Yield 0.00
- Turnover 49%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0
Morningstar’s Analysis HGHYX
Will HGHYX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 47.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 11.62 | 94M | Healthcare |
Johnson & Johnson | 6.71 | 54M | Healthcare |
Merck & Co Inc | 6.42 | 52M | Healthcare |
AbbVie Inc | 4.33 | 35M | Healthcare |
UnitedHealth Group Inc | 4.27 | 34M | Healthcare |
Elevance Health Inc | 3.00 | 24M | Healthcare |
Intuitive Surgical Inc | 2.94 | 24M | Healthcare |
Vertex Pharmaceuticals Inc | 2.89 | 23M | Healthcare |
CVS Health Corp | 2.64 | 21M | Healthcare |
Edwards Lifesciences Corp | 2.32 | 19M | Healthcare |